These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 16821257
1. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. Suh GH, Greenspan AJ, Choi SK. Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257 [Abstract] [Full Text] [Related]
2. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [Abstract] [Full Text] [Related]
4. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone. Rabinowitz J, Katz I, De Deyn PP, Greenspan A, Brodaty H. Int Psychogeriatr; 2007 Apr; 19(2):227-40. PubMed ID: 16879763 [Abstract] [Full Text] [Related]
8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
11. The effect of risperidone on nursing burden associated with caring for patients with dementia. Frank L, Kleinman L, Ciesla G, Rupnow MF, Brodaty H. J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545 [Abstract] [Full Text] [Related]
12. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication. Forester B, Vanelli M, Hyde J, Perez R, Ahokpossi C, Sribney W, Adkison L. Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660 [Abstract] [Full Text] [Related]
13. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Zuidema SU, Derksen E, Verhey FR, Koopmans RT. Int J Geriatr Psychiatry; 2007 Jul; 22(7):632-8. PubMed ID: 17136713 [Abstract] [Full Text] [Related]
14. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia. De Deyn PP, Wirshing WC. J Clin Psychiatry; 2001 Jul; 62 Suppl 21():19-22. PubMed ID: 11584983 [Abstract] [Full Text] [Related]
15. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia. Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):205-9. PubMed ID: 17020789 [Abstract] [Full Text] [Related]
16. Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes. Testad I, Aasland AM, Aarsland D. Int J Geriatr Psychiatry; 2007 Sep 30; 22(9):916-21. PubMed ID: 17323402 [Abstract] [Full Text] [Related]
17. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Chan WC, Lam LC, Choy CN, Leung VP, Li SW, Chiu HF. Int J Geriatr Psychiatry; 2001 Dec 30; 16(12):1156-62. PubMed ID: 11748775 [Abstract] [Full Text] [Related]
19. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living. Yoon JS, Kim JM, Lee H, Shin IS, Choi SK. Hum Psychopharmacol; 2003 Dec 30; 18(8):627-33. PubMed ID: 14696022 [Abstract] [Full Text] [Related]
20. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE. J Clin Psychiatry; 2001 Dec 30; 62 Suppl 21():29-32. PubMed ID: 11584986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]